초록 close

Purpose: MMP-2, 72 kDa-type IV collagenase, plays a major role in the migration and growth of tumor cells, a process that requires the disintegration of basement membrane. Activation of MMP-2 is correlated with the invasiveness of various tumors. The aim of this study was to determine the sequence-specific phosphorothioated oligodeoxynucleotides (ODNs) inhibiting the translation of MMP-2 mRNA and the subsequent invasiveness of tumor cells. Materials and Methods: Eight types of antisense ODNs were designed and each (8μg/ml) were transfected into HT1080 cells. The effects of these antisense ODNs on MMP expression were examined by gelatin zymography, Western blot, Northern blot and matrigel assay. Results: Antisense-5 (+904∼+923), antisense-6 (+1274∼ +1293) and antisense-7 (+1646∼+1665) reduced the MMP-2 activity of the culture supernatant in HT1080 fibrosarcoma cells. Treatment with antisense-6 showed inhibition of MMP-2 mRNA and protein, and in vitro invasion in a dose-dependent manner. Conclusion: Antisense-6 might be one of the therapeutic candidates for tumor invasion and metastasis. (Cancer Res Treat. 2002;34:444-449)


Purpose: MMP-2, 72 kDa-type IV collagenase, plays a major role in the migration and growth of tumor cells, a process that requires the disintegration of basement membrane. Activation of MMP-2 is correlated with the invasiveness of various tumors. The aim of this study was to determine the sequence-specific phosphorothioated oligodeoxynucleotides (ODNs) inhibiting the translation of MMP-2 mRNA and the subsequent invasiveness of tumor cells. Materials and Methods: Eight types of antisense ODNs were designed and each (8μg/ml) were transfected into HT1080 cells. The effects of these antisense ODNs on MMP expression were examined by gelatin zymography, Western blot, Northern blot and matrigel assay. Results: Antisense-5 (+904∼+923), antisense-6 (+1274∼ +1293) and antisense-7 (+1646∼+1665) reduced the MMP-2 activity of the culture supernatant in HT1080 fibrosarcoma cells. Treatment with antisense-6 showed inhibition of MMP-2 mRNA and protein, and in vitro invasion in a dose-dependent manner. Conclusion: Antisense-6 might be one of the therapeutic candidates for tumor invasion and metastasis. (Cancer Res Treat. 2002;34:444-449)